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Welcome to The University of New Mexico Department of Pathology’s PathFINDER. This sixth issue focuses
on exciting emerging research, successful research trainees and exemplary research funding. Feature articles
highlight emerging research on innovative models for ovarian cancer and on gene cutting approaches to myeloid

W I N T E R

disorders. The Department of Pathology is proud to be a lasting leader in biomedical and translational research.
With a heavy heart, we share a memorial tribute to Dr. William C. Black III, who served our patients, students and

2 01 7

faculty for over 40 years. Three faculty’s enduring accomplishments are highlighted as they retire: Dr. Thèrése
Bocklage, Dr. Walker (Kip) Wharton, and Dr. Jin Wu. Our esteemed faculty are speaking at conferences across

1. WELCOME FROM DOUGLA S P. CLA RK, MD

North America, including Vancouver, Seattle, Cleveland, Miami and Philadelphia. Please consider attending their
stimulating presentations and saying hello in person.

3. A LUMN I N EWS : JEFFREY MOORE, MD A N D YA P-Y EE CH ON G, M D

Our “Star Staff” article is a new feature and our first star is beloved by the residents.

5. IN N OVATIVE MODEL OF OVA RIA N CA N CER

The “Thomas M. Williams and Margaret G. Williams Endowment for Education and Training” recently funded

7. MOLECULA R GEN ETIC A PPROACHES TO CURIN G MY EL OI D D I S OR D ER S

the purchase of new educational equipment. I encourage you to make a contribution to a UNM Department of
Pathology fund (pathology.unm.edu/make-a-gift). You are investing in the future of Pathology. Your generosity

10. MA KE A GIFT

is appreciated and your contributions are managed
carefully.

11. THE UN DERGRA DUATE PIPELIN E N ETWORK S UMMER P R OG R A M

Hoping to hear from you and wishing you a joyful

13. S TA R S TA FF: CHRIS TINA GA RCIA-TEN ORIO

holiday season.
15. RES EA RCH FUN DIN G UPDATES
17. MEMORIA L TRIBUTE: WILLIA M C. BLACK III
19 . FACULTY RETIREES : KIP WHA RTON, JIN WU, THÈRÉSE B OCK L AG E
27. GRA DUATE S TUDEN T A N D POS TDOCTORA L FELLOW N EWS
29 . FACULTY N EWS, AWA RDS, A PPEA RA N CES
DOUGLAS P. CLARK, MD
33. ACKN OWLEDGEMEN TS

Professor & The Frederick H. Harvey Chair of
Pathology

Cover image: UNM Pathology faculty Tracy George, MD and Diane Lidke, PhD are working to understand the mechanism of mast cell proliferation
in mastocytosis. This immunofluorescence image shows mast cells (anti-tryptase, red) and actively dividing cells (anti-Ki67, green) in spleen tissue
from a mast cell leukemia patient. Cell nuclei are labeled blue. Image acquired by Ellen Hatch and Cheyenne Martin.
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ALUMNI NEWS
J EF F R E Y M OOR E , M D A ND YAP-YEE CHO NG, MD

JEFF RE Y M O O R E , MD

YAP-Y E E (C HRIS) C HONG, MD

Private Practice Pathologist, Kaiser Permanente

Vice Chair, Robert J Tomsich Pathology and Laboratory Medicine Institute

South Sacramento Medical Center, Sacramento, CA.

Cleveland Clinic, Cleveland, OH.

The sun was setting as we dropped into the Rio Grande valley. The

Dr. Chong was a hematopathology fellow in the UNM Department of

vibrant glow of the Sandia and Manzano mountains to the east

Pathology from 1998-99 and he kindly shared that Drs. Kathy Foucar

captivated us immediately. My family and I knew right then that

and Richard Larson had a huge influence on his career. During his

we would be moving to Albuquerque! My visit to UNM was the last

one year of hematopathology fellowship, Dr. Chong appreciated the

stop on an exhaustive interview tour by car that included visits to

professional training that gave him excellent diagnostic skills and

pathology residency programs on the west coast and throughout the

observed how much Drs. Foucar and Larson cared for the fellows

desert southwest.

as colleagues and people. Both helped Dr. Chong tremendously to
secure his first job as a Staff Pathologist at University Hospital in

Twenty-three years have passed since then, and I am continually

Cleveland and he has kept in touch with Drs. Foucar and Larson over

grateful for the UNM opportunity that I was provided. During those

the years.

short four years, I worked alongside a collegial group of fellow

Je ffrey M oore, M D

residents and interacted with some of the greatest mentors of my

Recently, Dr. Chong became the Vice Chair of Pathology and

lifetime. Several of these faculty members were key in helping me

Laboratory Medicine at the Cleveland Clinic, chairing the Regional

secure my cytopathology fellowship training program at UT MD

Operations Group, overseeing the labs of 11 hospitals and 17 family

Anderson Cancer Center: a path which opened the doors to a highly

Ya p-Ye e (C hri s) C hong, MD

rewarding private practice opportunity in the NASA / Space Center

health centers with emergency rooms, ambulatory surgery centers and
outpatient cancer clinics.

area of Houston. Several years ago, entering my career midpoint, I
felt it proper to move back home to California to be closer to family.

Dr. Chong enjoys gardening and Washington State wine. Sadly, wine

I am fortunate to have secured a very challenging position with the

tasting is on hold now that he has moved to Cleveland, Ohio. You may

Kaiser-Permanente Medical Group in Northern California where I will

reach Dr. Chong at: CHONGY@ccf.org

complete my career.

I often reflect back to my days at UNM, and do long to return to the
Valley to be reignited by the most beautiful skies I have ever seen!
DO YOU HAVE ALUMNI NE WS?
Please email your news, photos, and contact information to William Collins: wfcollins@salud.unm.edu. Your news
will be included in a future newsletter. Thank you in advance for contributing!
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F E AT U R E
EME R GIN G R E SE A RC H: INNOVATI VE MO DEL O F OVARI AN CANCER
W R I T T E N B Y M A R A S T E I N K A M P, P H D A N D B A R B A R A G R I F F I T H , M S

Even though ovarian

and, based on this understanding, develop targeted

The PDX mouse model has an additional advantage

cancer is a rare

treatment strategies. To evaluate targeted therapies

over cell lines in that it maintains the genetic

disease with only

in a model relevant to human disease, Dr. Steinkamp

heterogeneity of the human ovarian cancer cell

22,000 cases per year

has developed an innovative, biologically relevant

population. Therefore, these models can be used to

in the USA, it is the

approach using patient-derived cancer cells.

examine clonal variation in different tumors within the
same mouse or among mice carrying tumors derived

fifth highest cause
of cancer deaths in

Have you ever heard that “One man’s trash is another

from the same patient. Currently Dr. Steinkamp is

women. Diagnosis is

man’s treasure”? A collaborative study between

working with five PDX mouse models created from

often thwarted by the

clinicians and basic researchers at UNM allows

five different human ovarian cancer patients. Initially

generic symptoms of

researchers to obtain malignant ascites fluid from

it takes up to six months to establish tumors in these

bloating and common

ovarian cancer patients undergoing surgery here at

models, but subsequent generations have a faster

abdominal discomfort. By the time symptomatic

UNM. The ascites fluid is normally discarded, but it is a

disease onset. Solid tumors or spheroids from the mice

patients seek medical attention, ovarian cancer has

treasure to Dr. Steinkamp and the UNM Ovarian Cancer

can be transferred into multiple new NSG recipient

often disseminated throughout the abdomen and

Research Group, because this fluid contains immune

mice. These cohorts of mice can then be used to test

formed solid tumors on other organs. Although most

cells and free-floating ovarian cancer cell spheroids.

response to clinical treatments, such as targeted

patients initially respond to surgery and chemotherapy,

Steinkamp injects the isolated ovarian cancer spheroids

antibodies or small molecule inhibitors. Dr. Steinkamp

the majority will relapse with chemotherapy-resistant

from ovarian cancer patients into the abdomens of

uses human-specific fluorescent probes to monitor

disease. Five year survival is 45%. Dr. Steinkamp’s

immunodeficient NSG mice. Over time, these human

tumor growth in live mice during treatment. With these

research looks for ways to limit relapse by targeting

ovarian cancer cells will form solid tumors on organs in

models, we have shown a decrease in tumor burden

receptors expressed on the surface of cancer cells.

the mouse abdomen similar to what is seen in patients

with combination therapy of an ErbB inhibitor and

She is particularly interested in the ErbB family of

with disseminated disease. This model maintains many

paclitaxel. Dr. Steinkamp just received pilot funding

growth factor receptors that are frequently expressed

of the characteristics of the original disease, including

from the UNM Cancer Center to compare the RNA

in ovarian cancer tumors. These receptors can interact

expression of ErbB receptors, because these ovarian

expression patterns of solid tumors versus free-floating

with each other as homo-dimers or hetero-dimers and

cancer cells are never cultured as a monolayer; they

spheroids from the PDX models. Recent funding for Dr.

the type of interaction can impact the cell response.

grow in the natural, three dimensional, abdominal

Steinkamp’s research is provided by the New Mexico

In ovarian cancer, sixty percent of primary tumors

microenvironment of mice. These abdominally cultured

Spatiotemporal Modeling Center (STMC) lead by UNM

have more than one ErbB family member expressed.

human ovarian cancer cells are called “patient derived

Pathology Professor Bridget Wilson and by a young

Steinkamp’s group is testing drugs that inhibit all four

xenographs (PDXs)”. Yes, PDX models are a much

investigator research award from the American Cancer

members at once.

better tool for studying how ovarian cancer cells

Society (ACS) Institutional Research Grant (Ozbun,

function in their normal microenvironment than cancer

PI). This fall she also received funding from the Phi

cell lines grown as monolayers!

Beta Psi Charity Trust to further investigate pan-

Dr. M a ra Stei n ka m p

Dr. Steinkamp and her team want to understand how

collaborative research on drug penetration in ovarian
cancer tumors, which combined in vivo mouse studies
and computational modeling was published in Cancer
Research in 2016.
Our department is fortunate to have Dr. Steinkamp
working innovatively to create mouse models for
studying in vivo treatments for ovarian cancer.

ErbB inhibitors to target ovarian cancer. The team’s

the ErbB receptors are functioning in ovarian cancer
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F E AT U R E
EME R GIN G R E SE A RC H: M OL ECULAR GENETI C APPROACHES TO CU RI N G MYE LO I D D I S O RD E RS
W R I T T E N B Y C É D R I C C L E Y R A T, P H D A N D B A R B A R A G R I F F I T H , M S

D r. Céd r i c C l ey rat

Normal human bone

In a recent study of a familial case of CAMT, Dr. Cleyrat

cell surface through autophagy. This unconventional

marrow produces

and his team have identified a novel mutation of this

delivery of the mutant receptor to the cell surface

approximately 500

specific gene and, after a thorough characterization

partially restores binding to the ligand and proper

billion blood cells per

cell activation; opening the way for screening of

day, necessary for

Federal Drug Administration (FDA)-approved drugs

many functions such

that activate this autophagy pathway as potential

as immune defense,

alternate therapeutic agents to treat CAMT. In the

blood clotting, oxygen

genome editing approach, Dr. Cleyrat uses molecular

transport and more.

scissors, called the CRISPR-Cas9 system, to cut out

Diseases can result

the mutated genomic DNA and replace it with the

from bone marrow

wildtype gene in the cell’s nucleus. Cleyrat was able

dysfunctions, including
ceasing to make specific

to recover the stem cells contained in a cord blood
Figure 1

sample collected at birth from one of this family’s kids

cell types, ceasing to make functional cell types, or

using biochemical and imaging techniques, determined

and which was preserved in liquid nitrogen. He then

making too many of a specific cell type.

that, despite being still partially functional, the

applied the genome editing approach that he designed

receptor is incapable of reaching the cell membrane.

to these very few cells and demonstrated that after

Duchene muscular dystrophy, with first-in-human

Cédric Cleyrat, PhD is researching severe types of

Thus, the underlying basic biologic problem is that the

being genetically manipulated, these cells recovered

clinical trials just around the corner.

congenital amegakaryocytic thrombocytopenia

receptor doesn’t traffic to the cell surface, preventing

their ability to differentiate into megakaryocytic cells in

(CAMT), a rare inherited disorder detected at birth.

its activation by its ligand. Images in Figure 1 show that

vitro. The final goal would be to reinfuse these “edited”

On the other end of the spectrum, other mutations

Children born with CAMT have too few platelets,

wildtype (WT) Mpl receptor (green fluorescence) is

cells into the patient with the unique advantage to

in the bone marrow’ resident stem cells can lead to

cannot clot their blood and thus are susceptible to

present at the surface of the cell (green arrow head),

remove the risk of graft vs. host adverse reactions,

over-proliferation and cause myeloid cancers called

hemorrhaging. They also often suffer from severe

while the mutant Mpl receptor is trapped inside as

the most common reason for therapy failure in CAMT.

myeloproliferative neoplasms (MPN). The excessive

anemia or leukemic transformation later in life and the

visualized by the co-localization with a marker of

This work represents a proof-of-principle that genome

production of red blood cells or platelets triggers life-

only treatment currently available is a bone marrow

the endoplasmic reticulum in red (ER; an internal

editing could be used to cure this disease, once

threatening clotting problems and the development

transplant from a compatible donor. Interestingly,

compartment of the cells) rendering a strong yellow

approved for clinical application. A schematic summary

of fibrosis in the bone marrow can lead to its loss of

the children with CAMT carry mutations in the gene

color, which can be quantified using an image analysis

of the two rescue approaches used to restore the

function and sometimes to leukemia. Dr. Cleyrat, in

encoding the thrombopoietin receptor (called Mpl)

software. Scale bars = 5 µm.

mutant receptor function is presented in Figure 2.

collaboration with Dr. Bridget Wilson in UNM Pathology

that not only prevent hematopoietic stem cells

F i gure 2

and Dr. Cecilia Arana-Yi in UNM Internal Medicine, has

maintenance and self-renewal, but also impact their

Dr. Cleyrat is using two different approaches to rescue

In the future, Dr. Cleyrat is optimistic that the genome

initiated a clinical research protocol to study and bank

ability to differentiate into megakaryocytes, which are

the function of the receptor: 1) alternate trafficking

editing approach will work in humans. Similar efforts

MPN samples at UNM. Their clinical study, supported

the platelet-producing cells in the bone marrow.

and 2) genome editing. In the alternate trafficking

are ongoing to treat multiple other disorders, such

by funds from the Department of Defense and the

approach, he forces the trapped receptors to the

as sickle cell disease, specific kinds of blindness or

American Cancer Society, successfully enrolled nearly

continued on page 9
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EME R GIN G R E SE A RC H: M OL ECULAR GENETI C APPROACHES TO CU RI N G

MAKE A GIFT

M Y ELOID DISOR DE RS

D R . T H OM AS M . WI LLI A M S & M A R G A R ET G . WI LLI A M S E ND OW M E NT
F OR ED U CAT I ON A N D T RA I N I N G F U N D S U PPO RTS N EW EQ U I P M ENT
PU RCH AS E

conti nued from p ag e 8

W R I T T E N B Y W I L L I A M F. C O L L I N S , M FA

80 patients in just 20 months. With the expert help of

The UNM Department of Pathology is pleased to announce that funds from the “Dr. Thomas M. Williams &

staff member Eun Ho Choi and the UNM Human Tissue

Margaret G. Williams Endowment for Education and Training” have been used to purchase new video equipment

Repository, Cleyrat has banked multiple samples for

for use in educating fellows and residents. The department will produce a series of educational videos that will

each patient in order to follow disease progression and

be hosted online for residents and fellows in an effort to enhance their training. Topics could include basic safety,

treatment benefits. This new resource was also created

performing frozen sections, and the major dissections in each organ. This exciting new video equipment purchase

with the goal to provide UNM basic scientists with high

is in keeping with endowment’s mission to support the greatest educational and training needs within The

quality samples for their research effort and potentially

University of New Mexico Department of Pathology.

guide future therapeutic applications.
Dr. Cleyrat’s research on “Gene Editing Rescue of
a Novel MPL Mutant Associated with Congenital
Amegakaryocytic Thrombocytopenia (CAMT),” is
about to be published in September or October
2017 issue of “Blood Advances”. The MPL gene
encodes the myeloproliferative leukemia protein (aka
thrombopoietin receptor).
Dr. Ma r yam S ayah ( Re si d e n t ) an d D r.

Dr. Cleyrat is hoping to renew a Department of Defense

Sa m ue l Rey n o l d s ( A ssi st an t P ro fe sso r )

grant and will apply for an RO1 in October.

revi ewi n g cl i n i cal case s o n t h e t rai n i n g
m i c ros co p e.
photo: Re b e cca G u st af

Our department is excited to have Dr. Cleyrat as an
excellent cellular and molecular biologist working on
clinically driven, translational biomedical research.

Dr. Mi c h ae l H ar re l l ( Re si d e n t ) an d D r.
Sa m ue l Rey n o l d s ( A ssi st an t P ro fe sso r ) i n
t he gro ss ro o m , t rai n i n g o n p re p arat i o n o f
t i ss ue s fo r an ato m i c p at h o l o g y.
photo: Re b e cca G u st af
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F E AT U R E
U N DE R GRA DUAT E P IP E L IN E NETWO RK ( UPN) SUMMER RESEARCH PRO G RA M
W R I T T E N B Y J E N N I F E R M . G I L L E T T E , P H D , A S S O C I AT E P R O F E S S O R , U N M D E PA R T M E N T O F PAT H O L O G Y A N D D I R E C T O R , U N D E R G R A D U AT E P I P E L I N E N E T W O R K
SUMMER RESEARCH PROGRAM AND BARBARA B. GRIFFITH, MS

Developed and refined over the past eight years, the Undergraduate Pipeline Network (UPN) is a summer
undergraduate research program that cultivates students’ interest in research and helps them attain the skills
needed to apply for and eventually succeed in graduate/professional school. This experience also allows students
to discover and explore career options available to them by working as researchers, assisting faculty and learning
about new employment fields. Students gain the practical experience of applying their academic knowledge,
which better prepares them to have a profound effect on the research field. The 2017 UPN program was held
from May 31 – August 4, 2017 on the UNM HSC campus with a cohort of 35 students representing New Mexico and
many other states across the country. Over the ten summer weeks, UPN students participated full-time in all three
facets of the program: 1) independent research projects with their mentors, 2) skill-building seminars through
their weekly one credit course and 3) structured, collaborative/cohort building activities.

UPN Scholars were matched with research mentors from 6 major areas of study: Infectious Disease and Immunity,
Environmental Toxicology, Cancer, Brain and Behavioral Neuroscience, Cardiovascular Disease and Metabolism,
and Community-based health disparities research. UNM faculty representing at least seven different departments,
including the Department of Pathology, gave of their time and energy to serve as UPN mentors. In addition to
their mentors, the undergraduate students have contact with graduate students, post-doctoral fellows, medical
residents, clinical fellows, or research staff member throughout the program. Each undergraduate student has a
research project that provides the student with sufficient opportunity to demonstrate his/her ability to conduct
independent research. They attain skills necessary for successful graduate school applications and productive
post-baccalaureate education. They increase competency in presentation skills, team work with mentors and
multi-disciplinary team members, research etiquette, responsible conduct of novel research, and awareness of
scientific career options. The UPN Program awards each scholar summer financial support to cover a stipend and

The 2 01 7 U PN Sc hol a rs a nd U PN Di re c tor J e nni fe r G i l l e t te, PhD ( 2 n d f ro m r i g h t , m i d d l e row )

activity fees.

The 2017 UPN program culminated on August 4th with the UNM-HSC Summer Undergraduate Research
Symposium. Sixty students presented posters on their research to the UNM-HSC community. This summer, twelve
higher educational institutions in New Mexico had students participating in the UPN Summer Research Program.
Dr. Bill Shuttleworth, Regents’ Professor, UNM HSC Department of Neurosciences, delivered the Keynote seminar
entitled “Tsunamis in the Brain: Personal perspectives on Training and Opportunities In Biomedical Research.” The
day finished up with an awards presentation and a luncheon served for all of the scholars, their families and their
mentors. In summary, it was a proud day for research at the UNM HSC.
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S TA R S TA F F
C HR IST IN A GA RC IA-T E NORIO: A DREAM SPECI ALI ST FO R THE PAT H O LO GY RE S I D E N CY PRO G RA M
WRITTEN BY BARBARA GRIFFITH, MS

Christina Garcia-Tenorio MA, Medical Education Program Specialist, is the inaugural “STAR STAFF” to be
highlighted in PathFinder. Her “Star Staff” status has soared within this first year of her service to the Pathology
Residency program. The UNM Pathology Residents are delighted with Christina’s support, from her formal duties
to her extra efforts to make the residents feel appreciated during their long working hours. Christina loves her job
and it shows.

Ms. Garcia-Tenorio oversees the daily operations of the UNM Pathology Residency Program, including resident
recruitment, residency program accreditation, scheduling resident rotations, resident event planning, and
Brightspace online learning development.

•

RECRUITMENT: Christina schedules interview dates, makes hotel reservations and selects interview rooms at
the Office of the Medical Investigator.

•

ACCREDITATION: Christina provides annual updates to the Accreditation Counsel for Graduate Medical
Education (ACGME) including resident assessments.

•

ROTATIONS: Residents are scheduled for rotations at the Veteran’s Administration Medical Center (VAMC),
The University of New Mexico Hospital (UNMH), Office of the Medical Investigator (OMi) and TriCore
Reference Laboratories, based on the funding formula from Medicare, the OMI and UNMH. Might this rotation
scheduling be complex and sensitive? Oh, yes!

•

EVENT PLANNING: Christina organizes the Fall welcome party which allows residents to meet, greet and
network with fellows, faculty, and other residents. In 2017, all enjoyed the welcome party at Sandia Lakes
Recreation Area, especially the personalized “Koozies” crafted by Christina and given to each resident. The
Spring commencement party celebrates the accomplishments of the graduating pathology residents.

•

BRIGHTSPACE: In conjunction with Dr. Czuchlewski, Christina is developing content for residency rotations’
on line learning.

Christina balances her highly demanding work life with the delights of her family and relaxation of her crafts.
Christina is an avid crafter, leading workshops to teach crafts.

The UNM Department of Pathology is fortunate and proud to have Ms. Christina Garcia-Tenorio as a new Star
Staff!

C hri st i na G a rc i a -Te nori o a nd fa m i l y ( Em m a nue l , J a cob, a nd El i za be t h)
Photo t a ke n by L i nda Pl om e r of Lovi ngl y C a pt ure d Photogra phy.
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RESEARCH FUNDING
RE S E A R CH FUN DING A ND ACTI VI TI ES I N THE UNM DEPARTMENT O F

RE S E A RCH FU N D I N G ACH I E V E S N E W RECO RD AT T H E U NM H EA LTH

PAT HOLOGY IN 201 6 - 201 7

S CI E N CE S CE N T E R I N 2 01 6 - 2 01 7

W R I T T E N B Y D R . A N G E L A WA N D I N G E R - N E S S , V I C E C H A I R F O R R E S E A R C H

F R O M T H E O F F I C E O F T H E E X E C U T I V E V I C E C H A N C E L L O R F O R H E A LT H

AND DR. DIANE LIDKE, RESEARCH EXECUTIVE COMMITTEE MEMBER

SCIENCES, DR. RICHARD LARSON

In fiscal year 2017, Pathology faculty received over $22 million in research funding—13% of the record high

The UNM Health Sciences Center received a record $203 million in fiscal year 2017 in external grant funding

University of New Mexico Health Science Center’s research funding.

for biomedical research, capping 13 consecutive years of growth. The funding represents a 24% or $39 million
increase over the previous fiscal year. The Health Sciences Center has more than tripled its research funding since

We are pleased to announce the promotion to Associate Professor with Tenure for Dr. Jennifer Gillette and tenure

1998. The additional $39 million in external research funding translates into approximately 100-200 additional

for Associate Professor Dr. Tione Buranda.

research jobs at the UNM Health Sciences Center, which creates a “ripple effect,” making the UNM Health
Sciences Center a bright spot in New Mexico’s economy. UNM researchers have achieved major breakthroughs in

Our research faculty continue to provide leadership roles throughout the institution, with Angela Wandinger-Ness
as the Director of Education Training and Mentoring for the University of New Mexico Comprehensive Cancer

treating diabetes, cancer, multiple sclerosis, asthma, brain trauma and other diseases and disorders, leading to
improved health care delivery in our communities.

Center (UNM CCC) and Principal Investigator for high school to postdoctoral training programs and Dr. Gillette as
the Director of the Undergraduate Pipeline Network (UPN) undergraduate summer research internship program.
Dr. Bridget Wilson and Dr. Larry Sklar lead Cancer Research Programs in Translational Cell Signaling and Cancer
Therapeutics, respectively.

Pathology faculty have also assumed new leadership roles for Shared Research Resources, including Dr. Diane
Lidke as Director for the Fluorescence Microscopy Shared Resource, Dr. Jennifer Gillette as Director of the Flow
Cytometry Shared Resource and Dr. Mara Steinkamp as Director of the Animal Models Shared Resource.

The Pathology research faculty continue to be strong leaders in driving basic to translational sciences initiatives.
Drs. Wandinger-Ness and Buranda were awarded a National Science Foundation (NSF) Innovation Corps (I-Corps)
grant to launch their diagnostic technology as a start-up. Dr. Bridget Wilson and members of the SpatioTemporal
Modeling Center (Cannon, Cleyrat, Gillette Lidke, Neumann, Steinkamp and Wandinger-Ness) are translating
their research to cancer therapeutics and diagnostics. Dr. Larry Sklar leads the National Cancer Institute (NCI)
Experimental Therapeutics Program. Dr. Bearer spearheaded a Child Health Signature Program Symposium with
leading national experts. Dr. Tracy George was recently published in the New England Journal of Medicine for
her involvement with an international team that advanced the development of a drug proven to be effective in
treating Mastocystosis, which is a rare immune disorder.

The Department of Pathology’s research programs continued to thrive and make their mark in research with
approximately 100 publications.
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MEMORIAL TRIBUTE
WI L L IA M C . BLAC K III, MD: B ELOVED PRO FESSO R

Dr. William (Bill) Black, beloved Professor at the UNM Department of Pathology for over 40 years, passed away in

especially dogs. He was moderator to countless engaging conversations around the family dinner table. His

Albuquerque, NM on August 21, 2017, at the age of 86. Dr. Black is deeply missed.

children and grandchildren inherited this legacy of curiosity and discovery, which is a great tribute to Bill. Bill
is survived by his steadfast wife of 61 years, Katherine, sons William IV, Charlie, Jim, and daughter Elisabeth. He

Bill was born and raised in Denver, CO. He attended Colorado College for three years

had four grandchildren: Christine, Emma, Spencer, and Eva and one great grandson, Santiago. His dog Socks also

and briefly explored a career in professional golf before enrolling in Medical School

misses her papa. A private memorial service for Dr. Black was held on September 2, 2017 at his home.

at the University of Colorado in Denver. There he met Katherine whom he married in
1956. Dr. Black completed his internship at the University of Kansas Medical Center
before moving back to Penrose Hospital in Colorado Springs, CO. He completed his
training in Surgical Pathology at Columbia University in New York before fulfilling his
military service as a surgical pathologist at the Veteran’s Administration Hospital in
St. Louis. He served briefly as an Assistant Professor at Washington University. Dr.
Black became a life-long fan of the greatest baseball team on earth, the St. Louis
Cardinals.

D r. B l a c k c i rc a 1 9 69

In 1968, The University of New Mexico opened a new Medical School. Heavily
recruited and very excited about being part of a new program, Dr. Black gathered up
his family, and moved to Albuquerque, NM, where he thrived for 41 years, teaching

medical students, training pathology residents, and working as a surgical pathologist. His colleagues in The
University of New Mexico Department of Pathology held Dr. Black in high esteem for his gentle nature, his astute
mind, and his dedication to patient care. Dr. Black’s accomplishments were recognized by The University of
New Mexico, but he most prized the annual Hippo Awards presented by the UNM medical students to their most

DR. WILLIAM C. BLACK III

revered and entertaining teachers.

Dr. Black is keenly remembered for his deep love and interest in fly fishing which he shared with his entire
family, many friends and students. Dr. Black authored six books and numerous magazine articles on fly fishing
and fly tying. He also taught ‘Fly Fishing Basics’ every spring for 38 years, the longest running course in UNM’s
Continuing Education program. His son Jim continues to teach this course. Dr. Black and his wife Kathie enjoyed
fly fishing all across the globe, in Argentina, New Zealand, England, Scotland and Ireland. Dr. Black enjoyed
listening to opera, gardening, and cultivating different varieties of chili peppers.

Dr. Black had a natural curiosity, which enriched his life. He loved writing, reading Dickens, nature, and animals,
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F A C U LT Y R E T I R E E
WA L KE R ( KIP ) W HA R TON, P HD: I NNOVATI VE RESEARCHER ( AND H U MO RI ST !)
WRITTEN BY BARBARA GRIFFITH, MS

If you knew or worked with Dr. Kip Wharton during his extensive research career, count yourself lucky! Dr.

Kip Wharton retired quietly and peacefully, to spend time taking care of Debbie. She’s a lucky lady indeed. Dr.

Wharton is truly “one in a 325 million”. Kip’s creativity, sense of humor, and frank style made every day

Kip Wharton, his infectious laughter and his brilliant scientific mind will be missed at the UNM Department of

productive, cheerful and surprising.

Pathology.

Dr. Kip Wharton, Research Professor Emeritus in the UNM Department of Pathology, retired on July 1, 2017 after
contributing to research at UNM for a whirlwind sixteen years. Kip migrated to UNM after five years at the Moffitt
Cancer Center in Florida and 15 years at Los Alamos National Laboratories (LANL) in New Mexico. Kip reminisces
wildly about his post-doctoral fellowship years with Dr. Jack Pledger. Kip Wharton completed his PhD in
pharmacology with Dr. Barry Goz at the University of North Carolina at Chapel Hill in 1978; Kip was Dr. Goz’s first
and only graduate student. One and done!

Dr. Wharton’s research career primarily focused on cell cycle regulation, with over 110 publications and 7
graduate students to his credit. He was the first scientist to show that the epidermal growth factor receptor
(EGF-receptor) had to be internalized to get a mitotic response. His seminal papers in the mid 1970’s are still
critical and referenced by review articles written even in 2011. Kip collaborated with his esteemed colleagues
and mentors, including Jack Pledger, Janet Oliver, Larry Sklar and Lawrence Gurley. Kip was proud to have
played a role in recruiting Dr. Larry Sklar to split his time between LANL and UNM; Dr. Sklar is one of the most
serious and smartest scientists that Kip has known. Dr. Janet Oliver and Dr. Tom Williams inspired and supported
Dr. Wharton’s fruitful career. Kip greatly admired Dr. Gurley’s beautiful histone work and was saddened by Dr.
Gurley’s passing.

As a husband, father, and grandfather, Kip Wharton has shown even more dedication to his family than to his
career. That’s colossal dedication. His loving wife, Debbie, is the longest surviving Type I diabetes patient that Dr.
Burge at UNM has treated, ever. Kip shared that “no one should have had to endure marriage to him for 47 years
and Type I diabetes for 60 years”; Debbie is an angel and survivor! She has great anti-oxidant genes. Their son,
Tyler, enlisted in the US Marines after high school, and later pursued a career as a Program Manager at Sandia
National Laboratories- a job that Tyler loves. Grandson, Thomas, is taller than his father Tyler and has lunch with
his Grandfather Kip most Saturdays. Kip mentors Thomas on the value of avoiding unnecessary conflicts. May the
grandson learn from the “hard knock” experiences of the grandfather? Definitely, yes.
J a ne t Ol i ve r, PhD, Ki p Wha rton, PhD, a nd L a rry Sk l a r, PhD re l a xi ng at t he Indi go C row Re st au ran t .

Kip once told Sheryl Curtin that he wanted “to die in the laboratory - until it became a real possibility”! So Dr.
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F A C U LT Y R E T I R E E
JI N W U, M D : A “ T RA NSP LA NTED” HLA EXPERT EXTRAO RDI NAI RE
WRITTEN BY BARBARA GRIFFITH, MS

Ever cheerful, constantly optimistic and always adventurous, Dr. Jin Wu, Research Associate Professor, will

In retirement, Jin will pursue current hobbies including downhill skiing, Argentine tango dancing and traveling,

plunge into her retirement with the same enthusiasm that she brought to 25 years of human and non-human

as well as starting a new hobby - playing piano. Jin will visit her 90 year old Mom in China for a couple of months

primate HLA research at UNM.

and hopefully take her artistic husband to France to see the paintings of the masters. Their daughter, Mia, who
is in the midst of her MD, PhD program at the University of Illinois, was married on June 10, 2017 to Ian Bothwell,
PhD. Ah, life is good for Dr. Jin Wu and her family. We wish Jin all the best in her well-deserved retirement!

Dr. Jin Wu bravely emigrated from China to the USA in 1992, with Dr. Thomas M. Williams as her sponsor. In
Tianjin, China, Dr. Wu was an Assistant Professor specializing in ophthalmology with solid clinical skills, minimal
research experience and rudimentary English. Jin joined Dr. Tom Williams’ research lab, swiftly mastered English
and quickly grasped research techniques from the kind and proficient George Montoya. Dr. Williams had wisely
recruited Dr. Wu!

Going “above and beyond” and always accepting new scientific challenges was Dr. Wu’s daily mode of operation.
Multiple times, Jin generated critical preliminary data over a few weeks including weekends to allow Dr. Tom
Williams and Jin to apply for major research project funding. They obtained National Marrow Donor Program
(NMDP) funding to perform high resolution HLA typing in humans and National Institutes of Health (NIH) funding
to illuminate the Major Histocompatibility Complex (MHC) genes in non-human primates. Dubbed “The Monkey
Project”, the latter was Dr. Wu and Williams’ first NIH grant application, written over a weekend, and securing
$7 million for UNM and five subcontractors in the USA and Australia. What an astounding accomplishment! As a
relatively new lab in the HLA field, this UNM team successfully competed and collaborated with established labs
like those of Dr. Lee Ann Baxter-Lowe, Dr. Ann Begovich and Dr. Caroline Hurley. Drs. Williams’ and Wu’s HLA
laboratory became one of the best well-known and highly respected HLA laboratories in the nation.
Dr. J i n Wu downhi l l s k i i ng i n N ew Mexi co

Scientifically, Jin and Tom pioneered HLA locus specific amplifications and single molecule/single allele

J une 1 0, 2 01 7: Ia n a nd M i a o n t h e i r we d d i n g d ay i n n o r t h e r n
N ew Mexi co.

amplifications to separate and detect new human and primate alleles. They utilized hundreds of locus specific
primers and discovered over 700 new alleles in 3 species of macaques. The NIH funded the MHC studies in nonhuman primates to support new vaccine development. A new vaccine must be developed in 2 animal models,
including 1 non-human primate animal model.

Dr. Jin Wu had the ultimate respect for Dr. Tom Williams’ and his scientific enthusiasm, brilliance, and sense of
humor. Dr. Wu will be remembered for her hard work, scientific creativity, dedication, and positive “can do”
attitude.
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F A C U LT Y R E T I R E E
THÈ R É S E B OC K LAGE M D: A LI VE, ENERGI Z ED AND O FF TO HER “O L D K E N T U CKY H O ME ”
WRITTEN BY BARBARA GRIFFITH, MS

When you ﬁrst meet Dr. Thèrése Bocklage, you are relaxed by her calm demeanor, reﬁned manners, and

immeasurably grateful to Dr. Ribas for his unwavering commitment to immunotherapy research and practice.

perceptive mind. Quickly, you become awed by her accomplishments and true grit.
Dedicated even to the last day at UNM, Dr. Bocklage was ﬁnishing at least a dozen projects with residents
Dr. Bocklage arrived at UNM in 1991 as a fellow in surgical pathology, transitioned to an instructor for three years,

and fellows and was planning new collaborations between the UNM Department of Pathology and her new

pursued a cytopathology fellowship at Baylor Medical Center and returned to UNM as an Assistant Professor in

Department at the University of Kentucky at Lexington. The University of Kentucky, The University of New Mexico,

1995. During her career at UNM, Dr. Bocklage served 11 years as the Pathology Residency Director, started the

Stanford University, Vanderbilt University and The University of Vermont hope to collaborate on an NCI U01 Grant

Cytopathology Fellowship in 2003 serving as the Fellowship Director for all subsequent years, became Medical

over the next few years to study pathology resident learning with quantitative assessment and eye movement

Director of the Human Tissue Repository (HTR), serving in that position since 2008, and obtained a ﬁve year,

tracking.

$3 million dollar competitive contract from the National Cancer Institute (NCI) to help deﬁne best practices for
human tissue collection, preservation and storage. When Dr. Bocklage and her HTR team (Cathy Martinez, Fred

Dr. Thèrése Bocklage will greatly miss UNM and New Mexico, but looks forward to returning to the horse country

Schultz and Angela Meisner) secured this contract on their ﬁrst ever NCI funding application, Dr. Bocklage ran

of the Blue Grass State, being surrounded by the green of Kentucky and living close to family. Kentucky has been

to Dr. Tom Williams’ oﬃce and declared that “practice is over”. Astonishingly, she had received the phone call

her family’s home state for more than 200 years.

notiﬁcation of the contract award only minutes after Dr. Williams had gently counseled the HTR staﬀ that they
were unlikely to be successful but that the immense eﬀort was “good practice”. Quite an amazing ﬁrst time

The UNM Department of Pathology has been lucky to have Dr. Bocklage on our team for the past 25 years! We

accomplishment!

wish her well in her retirement and new academic pursuits.

Dr. Thèrése Bocklage has fun and fond remembrances of her 25 years in the UNM Department of Pathology. The
fun is exempliﬁed by the associated 1991 and 2017 “Alien Autopsy” photos, taken with other Pathology faculty
and residents. These photos were used in the national Directory of Pathology Residency Programs annual editions
and certainly made UNM stand out. Only in New Mexico, thanks to Roswell! Thèrése warmly recalled the “Pajama
Party Breakfast” held in honor of Dr. “Andy” Anderson’s farewell and highlighted with Dr. Tom McConnell’s new
poem “Ode to the Putative Man”. Apparently, Dr. Anderson used the word “putative” rather often. Dr. Bocklage
is grateful to Drs. Tom Williams for his sense of humor, support and always engaging impromptu chats, Mary
Lipscomb for her absolute integrity and exemplary leadership, and Charlie Key for his consistent positivity and
willingness to try new ventures and support them whole-heartedly. Dr. Bocklage appreciated the collegiality of
the pathologists, trainees and surgeons throughout her tenure at UNM.
Te re s a Qui nt a na , Adri a na Sa nc hez, MD, Thè ré s e B oc k l a ge,

On a more personal life history note, Thèrése commented how lucky she is to be alive; a life state that she

MD a nd Le s l ey Lom o, MD, i n a ha ppy m om e nt a f te r Adri a n a

never takes for granted. Her CT scans are clear 5 years after diagnosis and treatment for metastatic Stage 4B
melanoma. Dr. Antoni Ribas at the University of California at Los Angeles successfully treated Dr. Bocklage with
emerging immunotherapy in an early Phase IB trial. Thèrése and three other sustained complete responders are

k i ndl y gave e a c h of t he m hat s a s pa rt i ng gi f t s f rom he r h o m e
count ry of Ecua dor (e m phat i c a l l y N OT Pa na m a hat s) i n 2 017.
Dr. Sa nc hez ha d j ust com pl e te d he r cy topat hol ogy fe l l owsh i p.

continued on page 25
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T HÈ R É S E B OC K L AGE M D: A LI VE, ENERGI Z ED AND O FF TO HER “OL D
K E N T U C KY HOME ”

cont i nue d f rom p ag e 24

1 9 9 8 the o rig inal “Alien Auto p sy”. Left to r ight : Mike Mar key, MD, Thèrése B ocklage, MD,
J a so n H ees e, M D, Jeﬀ M o o re, M D, Chr ist ine Moore, MD, Mar k Wolz, MD, Gillian Redlich, MD,
M att Luke, M D, E liz ab eth M cK inley, MD, A my Har t , MD and Min Kang, MD as t he alien.

2 01 7 Reenac tm ent p ho to o f the “Alien Autopsy”. Left to r ight : Mat t Luke, MD, Thèrése
B ocklag e, M D, S am Reyno ld s , M D, Audra Ker win, MD, Emily Wolak, MD, Mar issa Tafoya, MD,
M i chael H arrell, M D, D ennis S o s novske, MD, Hannah Kastenbaum, MD (st anding in back),
M a rs ha Xio ng , M D, Favia D ubyk, M D, B en R amos, MD.
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G R A D U AT E S T U D E N T & P O S T D O C T O R A L F E L L O W N E W S

GRADUAT E ST U D E N T N E WS

TH ESI S DEFENSES

POSTDOC TORAL FE LLOWS / ME NTORS

Janie Byrum, a graduate student in Dr. Judy

Romica Kerketta, member of Dr. Jeremy Edwards’ lab,

Daniel Barto / Elaine Bearer

Cannon’s lab, received the American Association of

defended her PhD thesis on June 15, 2017.

Carolina Franco Nitta / Diane Lidke

Immunologists Careers in Immunology Fellowship.

Stephanie Jerman / Angela Wandinger-Ness

Byrum also was selected as an Infectious Disease and

Zohreh Karimi, member of Dr. Aaron Neumann’s lab,

Elton Jhamba / Diane Lidke

Immunity T32 fellow.

completed her MS on April 11, 2017.

Alfreda Nelson / Bridget Wilson
Charuta Palsuledesai / Angela Wandinger-Ness

Dr. Yolanda McDonald, a recent graduate student

Rina Sylejmani, member of Dr. Aaron Neumann’s lab,

Lynette Rios / Larry Sklar

in Dr. Cosette Wheeler’s laboratory, defended

completed her MS on July 14, 2017.

Therese Shideler / Angela Wandinger-Ness

her PhD thesis on May 19, 2017 and secured

Salina Torres / Cosette Wheeler

an Assistant Professor position at Vanderbilt

Yolanda McDonald, member of Dr. Cosette Wheeler’s

University in Nashville, TN. Dr. McDonald is faculty

lab, defended her PhD thesis on May 19, 2017

Nesia Zurek / Aaron Neumann

in the Department of Human and Organizational
Development.

G RA DUATE STUDENTS / MENTO RS

Brianna Mulligan, a graduate student in Dr. Elaine

Eduardo Anaya / Aaron Neumann

Bearer’s laboratory, will be presenting her poster

Janie Byrum / Judy Cannon

entitled “Differential epigenetic patterns in children

Rohan Choraghe / Aaron Neumann

with documented trauma” at the Society for

Prashant Dogra / Elaine Bearer

Neuroscience annual meeting in Washington, DC on

Akram Etemadi Amin / Aaron Neumann

November 14, 2017. Mulligan was also invited to give a

Muskan Floren / Jennifer Gillette

press conference on “Stress and the Brain” based on

Cristina Flores-Cadengo / Diane Lidke

her poster’s abstract, and the press conference will

William Kanagy / Diane Lidke

be moderated by Dr. Bruce McEwen of Rockefeller

Carmen Martinez / Aaron Neumann

University. As a first year graduate student, Mulligan’s

Brianna Mulligan / Elaine Bearer

selection for the press conference is distinctive

Dominique Perez / Larry Sklar

honor. Only 4 or 5 abstracts are selected per press

Derek Rinaldi / Diane Lidke

conference and over 15,000 abstracts are submitted

Melanie Rivera / Angela Wandinger-Ness

to Society for Neuroscience every year. This press

Chelsea Saito-Reis / Jennifer Gillette

conference will be held on November 13, 2017.

Emanuel Salazar Cavazos / Diane Lidke
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F A C U LT Y N E W S , A W A R D S , A P P E A R A N C E S

FAC ULT Y RE T I R E E S
Walker (Kip) Wharton, PhD Research Professor, retired

Nancy Joste, MD Professor, received the Leonard M.

Academy of Pathology Annual Meeting in Vancouver,

Napolitano Award from the UNM School of Medicine’s

BC, Canada.

Alumni Association in October of 2017.

as of July 1, 2017.

Sarah Lathrop, DVM, PhD
2 018 FACULTY A PPEA RA NCES

February 20, 2018: “Emerging Infectious Diseases and

Glynnis Ingall, MD PhD Professor, retired as of July 1,
2017; continuing as .25 FTE working retiree.

the Medical Examiner: The Challenges and Rewards
Douglas P. Clark, MD

of Effective Surveillance”, National Association of

April 16, 2018: “James E. Wheeler Distinguished

Medical Examiners Interim Scientific Meeting at the

Thèrése Bocklage, MD Professor, retired as of

Alumnus Lecture”, Department of Pathology and

American Academy of Forensic Sciences 2018 Annual

September 1, 2017.

Laboratory Medicine, University of Pennsylvania,

Conference, Seattle, WA.

Philadelphia, PA.
Jin Wu, MD Research Associate Professor, retired as of
December 31, 2017.

Kathryn Foucar, MD
January 25, 2018: “Acute Myeloid Leukemia “, lecture

N EW FAC ULT Y

for the Tutorial on Neoplastic Hematopathology, Miami,
FL

Elena Trabaudo, MT Lecturer II, Medical Laboratory
Sciences Program, started August 1, 2017.

January 25, 2018: “B- and T-Cell Chronic
Lymphoproliferative Neoplasms”,

Jain Zhou, MD, PhD Assistant Professor, Anatomic

lecture for the Tutorial on Neoplastic

Pathology, started August 4, 2017. Board certified in

Hematopathology, Miami, FL

anatomic and clinical pathology.
Tracy George, MD
FAC ULT Y AWA R DS

April 5, 2018: “Current Concepts on Mastocytosis”,
Cleveland Clinic Grand Rounds, at the Department of

Karissa Culbreath PhD Clinical Assistant Professor,

Pathology and Laboratory Medicine at the Cleveland

received the New Mexico Women of Science,

Clinic, Cleveland, OH.

Technology, Engineering and Math (STEM) award in
August of 2017.

March 21, 2018: “Bone Marrow Manifestations of
Systemic Disease”, United States and Canadian
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F A C U LT Y A N D T R A I N E E R E C E N T C H I L D R E N

Dr. Shaun Yang, Assistant Professor,

Dr. Brittany Coffman, Co-Chief

and his wife, Yi Zhang, along with

Resident Physician, and her husband

big brother Lucas Yang, welcomed

Dr. Ross Clark welcomed their baby

their baby boy, Miles Yang, on July

girl, Charlotte Blaine Clark, on July

16, 2017.

30, 2017.

Dr. Joshua Routh, Molecular

Dr. Sarah Kelting, Hematopathology

Genetics Fellow, and his wife

Fellow and her husband Jonas

Kristen welcomed their baby boy,

Malever welcomed their baby girl,

Ezra Augustus Routh, on August 1,

Silvie Marie Malever, on July 6, 2017.

2017.

Dr. Aisha Sethi and her husband
welcomed their baby girl, Evalina
Sethi Arora, on October 24, 2017.

Dr. Glynnis Ingall’s son, Jonah Katz, and her daughterin-law, Tiana Zellet, welcomed their daughter, Adira
Rose Katz, on October 13, 2017. This is Dr. Ingall’s first
Dr. Kathy Foucar’s Son, Jim Foucar, daughter-in-law,

grandchild.

Morgan Foucar, and granddaughter/big sister, Avery,
welcomed their baby boy, Rowan Foucar, on August
2, 2017.
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